Atavistik Bio logo

Atavistik Bio

Healthcare
atavistikbio.com
11-50 employees

Atavistik Bio is a biotechnology company focused on developing precision allosteric therapeutics for serious unmet patient needs, particularly in oncology. The company leverages allostery to create superior efficacy and tolerability profiles, with ATV-1601, an allosteric inhibitor for solid tumors, expected to enter clinical trials in early 2025. Led by experienced drug hunters and backed by top-tier investors like The Column Group, Nextech Invest, and Lux Capital, Atavistik Bio aims to accelerate the discovery of innovative treatments.

Open Positions

Executive Assistant

Cambridge, Massachusetts, United States
Posted Feb 6
Full Time

5+ years of professional administrative support experience, 2+ years supporting executive/C-level leaders

Administration JobsBusiness Operations & Strategy Jobs

Senior Director, Toxicology

Cambridge, Massachusetts, United States
Posted Feb 19
Full Time

PhD in Toxicology or Pharmacology, DVM, or related field, and at least 10 years of experience in the life science industry

Other